港股早評:三大指數高開 科技股、內險股、黃金股表現活躍
隔夜美股三大指數收跌,中概指數升1.39%。連續2日反彈的港股再度高開,恒指升0.4%,國指升0.37%,恒生科技指數升0.29%。盤面上,大型科技股集體上升,京東升2%,快手升1.68%,阿里巴巴、網易升超1.2%,百度、騰訊、美團飄紅,小米再度下跌1.35%;內險股升幅明顯,新華保險績後升超5%,中國太保、中國太平、中國平安均升超1%;國際金價狂飆刷新高!黃金股全線上升,家電股部分走高,創維集團績後升6.67%,體育用品股、濠賭股、生物醫藥股、食品飲料股齊升。另一方面,重型機械股跌幅較大,尤其是森松國際績後大跌超13%,石油股、鋰電池股、半導體股走低,中芯國際、中國海洋石油跌超2%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.